US Broker Ratings

Telix Pharmaceuticals (TLX) Stock Analysis: Exploring a Promising 235% Upside Potential

In the dynamic world of biotechnology, Telix Pharmaceuticals Limited (ASX: TLX) stands out as a compelling investment opportunity. With a remarkable potential upside of 235%, this Australian healthcare company is..

Tempus AI, Inc. (TEM) Stock Analysis: Unveiling a 69.23% Potential Upside in Healthcare Innovation

Tempus AI, Inc. (NASDAQ: TEM) is rapidly emerging as a compelling player in the healthcare technology sector, specifically within the health information services industry. With a market capitalization of $9.24..

Revolution Medicines, Inc. (RVMD) Stock Analysis: A Deep Dive into Its 26.62% Potential Upside

Revolution Medicines, Inc. (NASDAQ: RVMD) is capturing investor attention with its innovative approach to treating RAS-addicted cancers and its enticing potential upside of 26.62%. As a clinical-stage precision oncology company,..

Option Care Health, Inc. (OPCH) Stock Analysis: A 12.42% Upside Potential Awaits Investors

Option Care Health, Inc. (NASDAQ: OPCH) has positioned itself as a key player in the healthcare sector, specifically within the medical care facilities industry. Headquartered in Bannockburn, Illinois, the company..

Stevanato Group S.p.A. (STVN) Stock Analysis: Exploring the 75% Upside Potential

Stevanato Group S.p.A. (NYSE: STVN), a prominent player in the healthcare sector, is capturing investor attention with its robust growth trajectory and substantial upside potential. With a current market capitalization..

Guardant Health, Inc. (GH) Stock Analysis: Riding the 19.45% Potential Upside in Precision Oncology

Guardant Health, Inc. (GH) is making waves in the healthcare sector with its innovative approach to diagnostics and research. As a leader in precision oncology, the company provides cutting-edge blood..

BridgeBio Pharma, Inc. (BBIO) Stock Analysis: Impressive Revenue Growth and 30.63% Potential Upside for Investors

BridgeBio Pharma, Inc. (NASDAQ: BBIO) is carving a niche in the biotechnology sector with a focus on developing therapeutics for genetic diseases and cancers. Based in the United States, this..

Madrigal Pharmaceuticals, Inc. (MDGL) Stock Analysis: Exploring a 44% Upside Potential

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) is catching the attention of investors with an enticing potential upside of 44.41%. As a prominent player in the biotechnology industry, Madrigal is focused on..

Axsome Therapeutics, Inc. (AXSM) Investor Outlook: Exploring a Potential 18.89% Upside in CNS Innovations

Axsome Therapeutics, Inc. (NASDAQ: AXSM) has become a prominent player in the biotechnology sector, focusing on novel therapies for central nervous system (CNS) disorders. With a market capitalization of $9.14..

ADMA Biologics Inc (ADMA) Stock Analysis: Unlocking a 59.52% Upside in the Biotech Arena

ADMA Biologics Inc (NASDAQ: ADMA) stands as a compelling opportunity in the healthcare sector, particularly within the biotechnology industry. With a market capitalization of $3.84 billion, this biopharmaceutical company is..

AstraZeneca PLC (AZN) Stock Analysis: Navigating a -24.17% Potential Downside Amid Strong Revenue Growth

AstraZeneca PLC (NASDAQ: AZN), a stalwart in the healthcare sector, has captured the attention of investors worldwide. With a market capitalization of $318.66 billion, this UK-based biopharmaceutical giant operates at..

Nuvalent, Inc. (NUVL) Stock Analysis: A 41.49% Potential Upside in the Biotechnology Sector

Nuvalent, Inc. (NASDAQ: NUVL), a clinical-stage biopharmaceutical company, is making waves in the biotechnology sector with its innovative approach to treating cancer. With a market capitalization of $7.83 billion, Nuvalent..

Ascendis Pharma A/S (ASND) Stock Analysis: A 31.7% Potential Upside in Biotech Innovation

Ascendis Pharma A/S (NASDAQ: ASND) is making waves in the biotechnology sector with its innovative TransCon-based therapies, capturing the attention of investors seeking growth in the healthcare industry. As a..

Smith & Nephew SNATS, Inc. (SNN) Stock Analysis: Exploring a Stable Player with a 2.11% Dividend Yield and Modest Growth Prospects

Smith & Nephew SNATS, Inc. (NYSE: SNN) is a prominent entity in the healthcare sector, specifically within the medical devices industry. With a market capitalization of $15.36 billion, this UK-based..

TG Therapeutics, Inc. (TGTX) Stock Analysis: A 55.89% Potential Upside in the Biotech Space

TG Therapeutics, Inc. (NASDAQ: TGTX) stands as a compelling player in the biotechnology sector, particularly for investors keen on the healthcare industry. With a market capitalization of $4.52 billion, TG..

Vaxcyte, Inc. (PCVX) Stock Analysis: A Biotech Gem with 88.75% Potential Upside

Vaxcyte, Inc. (NASDAQ: PCVX) is catching the attention of investors with its potential for significant upside, estimated at an impressive 88.75%. As a clinical-stage company making strides in vaccine innovation,..

Dr. Reddy’s Laboratories Ltd (RDY) Stock Analysis: Navigating a 2.34% Potential Upside Amidst Healthcare Ambitions

Dr. Reddy’s Laboratories Ltd (NYSE: RDY) stands as a formidable player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry. With a market capitalization of $11.87..

Fresenius Medical Care AG (FMS) Stock Analysis: Unveiling a 15% Upside Potential in the Healthcare Sector

Fresenius Medical Care AG (NYSE: FMS), a leader in the healthcare sector specializing in dialysis and related services, presents an intriguing opportunity for investors with a potential upside of 15.44%...

Solventum Corporation (SOLV) Stock Analysis: A Promising 18.13% Upside in the Healthcare Sector

Solventum Corporation (NASDAQ: SOLV), a dynamic player in the healthcare sector, has been capturing investor attention with its robust product offerings and strategic market position. Headquartered in Maplewood, Minnesota, the..

Henry Schein, Inc. (HSIC) Stock Analysis: Navigating Growth in Healthcare Distribution with a 5.20% Revenue Surge

Henry Schein, Inc. (NASDAQ: HSIC) stands as a pivotal player in the healthcare distribution sector, a cornerstone in the medical distribution industry with a substantial market capitalization of $9.48 billion...

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds